0000002230-19-000026.txt : 20190314
0000002230-19-000026.hdr.sgml : 20190314
20190314160212
ACCESSION NUMBER: 0000002230-19-000026
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20181231
FILED AS OF DATE: 20190314
DATE AS OF CHANGE: 20190314
EFFECTIVENESS DATE: 20190314
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADAMS DIVERSIFIED EQUITY FUND, INC.
CENTRAL INDEX KEY: 0000002230
IRS NUMBER: 134912740
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-00248
FILM NUMBER: 19681051
BUSINESS ADDRESS:
STREET 1: 500 EAST PRATT STREET
STREET 2: SUITE 1300
CITY: BALTIMORE
STATE: MD
ZIP: 21202
BUSINESS PHONE: 4107525900
MAIL ADDRESS:
STREET 1: 500 EAST PRATT STREET
STREET 2: SUITE 1300
CITY: BALTIMORE
STATE: MD
ZIP: 21202
FORMER COMPANY:
FORMER CONFORMED NAME: ADAMS DIVERSIFIED EQUITY FUND
DATE OF NAME CHANGE: 20150331
FORMER COMPANY:
FORMER CONFORMED NAME: ADAMS EXPRESS CO
DATE OF NAME CHANGE: 19920703
N-CEN
1
primary_doc.xml
X0201
N-CEN
LIVE
0000002230
XXXXXXXX
811-00248
N-2
Adams Diversified Equity Fund, Inc.
811-00248
0000002230
5493005W7G81BNPP7M23
500 East Pratt Street
Suite 1300
Baltimore
21202
US-MD
US
410-752-5900
Adams Diversified Equity Fund, Inc.
500 East Pratt Street
Suite 1300
Baltimore
21202
410-752-5900
All accounts, books, and documents required to be maintained by the Registrant pursuant to Section 31(a) of the Investment Company Act of 1940 and Rules 31a-1 through 31a-3 thereunder are maintained at the office of the Registrant except all those relating to the activities of the Fund's Custodian and Transfer Agent.
The Northern Trust Company
50 South La Salle Street
Chicago
60603
312-630-6000
All accounts, books and documents relating to the activities of the Fund's Custodian and Securities Lending Agent.
American Stock Transfer and Trust Company, LLC
6201 15th Avenue
Brooklyn
11219
718-921-8200
All accounts, books and documents relating to the activities of the Fund's Transfer Agent.
Y
N
N-2
Y
Mark E. Stoeckle
N/A
Y
Enrique R. Arzac
N/A
N
Kenneth J. Dale
N/A
N
Frederic A. Escherich
N/A
N
Roger W. Gale
N/A
N
Lauriann C. Kloppenburg
N/A
N
Kathleen T. McGahran
N/A
N
Craig R. Smith
N/A
N
Enrique R. Arzac
N/A
N
Janis F. Kerns
N/A
500 East Pratt Street
Suite 1300
Baltimore
21202
XXXXXX
Y
N
N
N
N
N
PricewaterhouseCoopers LLP
238
N/A
N
N
N
N
N
Adams Diversified Equity Fund, Inc.
5493005W7G81BNPP7M23
Y
N/A
N
N
Y
N
N
The Northern Trust Company
6PTKHDJ8HDUF78PFWH30
N
N
Revenue sharing split
Administrative fee
Cash collateral reinvestment fee
38224374.000000000000
62724.000000000000
N/A
N
N
N
N
American Stock Transfer and Trust Company, LLC
084-00416
254900TS5EWP83BEOU02
N
N
N
ICE Data Pricing & Reference Data, LLC
5493000NQ9LYLDBCTL34
N
N
The Northern Trust Company
6PTKHDJ8HDUF78PFWH30
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
N
American Stock Transfer and Trust Company, LLC
254900TS5EWP83BEOU02
N
N
N
N
Morgan Stanley & Co. LLC
8-15869
000008209
9R7GPTSO7KV3UQJZQ078
471690
Sanford C. Bernstein & Co., LLC
8-52942
000104474
549300I7JYZHT7D5CO04
98955
Deutsche Bank Securities Inc.
8-17822
000002525
9J6MBOOO7BECTDTUZW19
76344
Goldman Sachs & Co. LLC
8-129
000000361
FOR8UP27PHTHYVLBNG30
64578
Credit Suisse Securities (USA) LLC
8-422
000000816
1V8Y6QCX6YMJ2OELII46
58695
Stifel Nicolaus & Co. Inc.
8-1447
000000793
5WUVMA08EYG4KEUPW589
49672
Barclays Capital Inc.
8-41342
000019714
AC28XWWI3WIBK2824319
43791
Cowen & Company, LLC
8-22522
000007616
549300WR155U7DVMIW58
42201
Robert W. Baird & Co. Inc.
8-497
000008158
549300772UJAHRD6LO53
34936
Empirical Research Partners LLC
8-65590
000123520
N/A
29326
1164360
Fidelity Distributors Corporation
8-8775
000006848
549300XG82GC06JU1803
45001685
Legg Mason Investor Services, LLC
8-53089
000109064
N/A
40000000
85001685
Y
1809865811
Common stock
N/A
N
N
Common stock
N
N
N
0
0.56
12.62
14.89
false
false
true
false
false
false
false
false
false
false
false
INTERNAL CONTROL RPT
2
ADX.txt
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Shareholders of Adams Diversified Equity Fund,
Inc.
In planning and performing our audit of the financial statements of Adams
Diversified Equity Fund, Inc. ("the Fund") as of and for the year ended
December 31, 2018, in accordance with the standards of the Public Company
Accounting Oversight Board (United States) (PCAOB), we considered the Funds
internal control over financial reporting, including controls over safeguarding
securities, as a basis for designing our auditing procedures for the purpose of
expressing our opinion on the financial statements and to comply with the
requirements of Form N-CEN, but not for the purpose of expressing an opinion on
the effectiveness of the Funds internal control over financial reporting.
Accordingly, we do not express an opinion on the effectiveness of the Fund's
internal control over financial reporting.
The management of the Fund is responsible for establishing and maintaining
effective internal control over financial reporting. In fulfilling this
responsibility, estimates and judgments by management are required to assess
the expected benefits and related costs of controls. A companys internal
control over financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally
accepted accounting principles. A company's internal control over financial
reporting includes those policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the company; (2)
provide reasonable assurance that transactions are recorded as necessary to
permit preparation of financial statements in accordance with generally
accepted accounting principles, and that receipts and expenditures of the
company are being made only in accordance with authorizations of management
and directors of the company; and (3) provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use or disposition
of a companys assets that could have a material effect on the financial
statements.
Because of its inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. Also, projections of any evaluation of
effectiveness to future periods are subject to the risk that controls may
become inadequate because of changes in conditions, or that the degree of
compliance with the policies or procedures may deteriorate.
A deficiency in internal control over financial reporting exists when the
design or operation of a control does not allow management or employees, in
the normal course of performing their assigned functions, to prevent or detect
misstatements on a timely basis. A material weakness is a deficiency, or a
combination of deficiencies, in internal control over financial reporting,
such that there is a reasonable possibility that a material misstatement of
the company's annual or interim financial statements will not be prevented or
detected on a timely basis.
2
Our consideration of the Funds internal control over financial reporting was
for the limited purpose described in the first paragraph and would not
necessarily disclose all deficiencies in internal control over financial
reporting that might be material weaknesses under standards established by the
PCAOB. However, we noted no deficiencies in the Funds internal control over
financial reporting and its operation, including controls over safeguarding
securities that we consider to be material weaknesses as defined above as of
December 31, 2018.
This report is intended solely for the information and use of the Board of
Directors of Adams Diversified Equity Fund, Inc. and the Securities and
Exchange Commission and is not intended to be and should not be used by
anyone other than these specified parties.
Baltimore, MD
February 15, 2019